Start With What Actually Changed
A changed recommendation can come from several different places, and they do not mean the same thing. Your clinician may have received a new pathology report, a repeat biopsy result, a different imaging interpretation, or a genomic test. Or the change may reflect a new discussion about your priorities, such as avoiding urinary or sexual side effects, or accepting more intensive treatment for a higher-risk cancer. Sometimes the recommendation changes because the first advice was based on incomplete information.
Before you contact any hospital in China, write down the old recommendation and the new one in one or two sentences each. Then write what you believe triggered the change. If you cannot state the trigger clearly, that is the first question to ask your current treating team. A records-based review in China cannot resolve a disagreement if the reason for the change is still unclear.
This matters because a remote opinion depends on the file it receives. If the file contains the old biopsy report but not the new one, or the old imaging but not the repeat scan, the reviewer is working with a different case than the one your local team is now discussing. The goal is not to collect every document you have ever received. It is to send the records that explain the current recommendation.
The Diagnosis Details a Reviewer Needs
Prostate cancer recommendations depend heavily on the exact diagnosis. Ask your local team for the pathology report from the biopsy, including the Gleason score or grade group, the number of positive cores, and the percentage of cancer in each core. If you have had prostate imaging, such as multiparametric MRI, ask for the report and the images, not only the written summary. If a genomic or molecular test was done on the biopsy tissue, include that report as well.
These details are not interchangeable. A Gleason 6 cancer in one core is a different clinical situation from a Gleason 8 cancer in several cores, even if both are called prostate cancer. A changed recommendation often reflects exactly this kind of distinction. When you send records for review, the pathology report and the imaging report should be the original documents, translated if they are not in English or Chinese, rather than a paragraph you wrote summarizing them.
If any of these documents are missing, say so in your enquiry rather than waiting until you have everything. A reviewer can tell you what is missing and whether it can be obtained. Do not ask a hospital in China to diagnose you from a summary alone, and do not assume that a preliminary reply means the case has been accepted for treatment.
Previous Treatment Changes the Question
If you have already had treatment, the new recommendation has to be read in that context. Previous surgery, radiotherapy, hormonal therapy, or focal treatment such as HIFU changes what options remain and what risks they carry. Ask your local team for the treatment summary: what was done, when, at what dose or technique, and what the follow-up PSA results have shown since.
This is also where a changed recommendation can be genuinely useful rather than confusing. A clinician reviewing your case in China may see a pattern in the PSA history or in the imaging that suggests a different next step. But that opinion is only as good as the treatment history you provide. If you had radiotherapy five years ago and the new advice does not mention it, the advice may be based on an incomplete picture.
Radical prostatectomy removes the prostate for selected prostate cancers, and robotic instruments are controlled by the surgeon. That is a factual description of one option, not a recommendation for your case. Whether surgery, radiotherapy, surveillance, or another approach is suitable depends on your diagnosis, previous treatment, and goals, and only your treating clinicians can decide that with you.
Cancer Control and Function Goals Are Part of the Decision
Two patients with similar pathology can receive different recommendations because they weigh cancer control and function differently. Urinary continence and sexual function after treatment are real concerns, and so is the risk of cancer progression. A changed recommendation may reflect a clearer conversation about which of these matters more to you, or a new understanding of how your cancer is likely to behave.
When you ask for a review in China, state your goals explicitly. For example: I want the highest realistic chance of cancer control, and I am willing to accept a higher risk of urinary or sexual side effects. Or: I want to avoid surgery if surveillance is a reasonable option for my diagnosis. This is not a treatment request. It is information that helps a clinician understand why the recommendation changed and what a useful second opinion would address.
No outcome is guaranteed with any prostate cancer treatment. Ask your treating clinicians about evidence-based risk estimates and the uncertainty around them, rather than expecting a fixed number. A review can discuss ranges and trade-offs; it cannot promise a specific result.
What to Send, and What to Ask For
A useful records package for a changed prostate cancer recommendation is smaller than most people expect. It should contain the documents that explain the current advice, not every scan and note from the past decade. The practical items are the biopsy pathology report, the prostate imaging report and images, the most recent PSA results with dates, the previous treatment summary if any, and a short statement of your goals and the specific question you want answered.
Send these through the channel the hospital or coordination service provides, and ask how the records will be handled and who will review them. If you are working with ChinaSpecialistCare, the initial case review is free and checks whether the available diagnosis, records, and your main question are clear enough to suggest a next step. It is not a diagnosis and does not promise acceptance. A proxy consultation, where a doctor takes your records to a hospital specialist for a records-based opinion while you remain at home, is optional and not a prerequisite for every appointment.
Ask the receiving clinician one focused question: given these records, what would you need to confirm before advising on my situation? That question is more useful than asking for a treatment recommendation from a distance. It also tells you whether the reviewer has enough information to say anything meaningful about the changed advice.
Practical Boundaries Before You Travel
A changed recommendation is not automatically a reason to travel. It is a reason to clarify the diagnosis, the records, and your goals first. If the change is based on a new pathology result, the most useful step may be a pathology review rather than a surgical consultation. If it is based on imaging, a radiology review may be the priority. If it is based on your goals, a conversation with your local team may resolve it without any overseas enquiry.
Do not delay necessary local care while you explore options in China. If your symptoms are worsening, or if your local clinician has advised urgent treatment, that advice takes priority. An overseas enquiry can proceed in parallel, but it should not replace timely assessment where you are.
If you do decide to pursue care in China, ask the hospital how its written estimate works and what it includes, excludes, or leaves undecided. Hospital consultation fees, tests, treatment, medicines, and rooms are paid to the hospital or the relevant provider, and coordination fees are separate. Ask the named provider about its actual quote rather than relying on a general figure.
The next step is simple: write down the old recommendation, the new recommendation, and what you believe changed. Gather the pathology report, imaging report, recent PSA results, and any previous treatment summary. Then send a short enquiry describing your situation and the specific question you want answered. An initial enquiry is free and does not require buying a proxy consultation. The hospital decides whether your case is suitable for review or treatment.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.